PATH | VRL
Menu

Cost-Effectiveness of Introducing a Rotavirus Vaccine in Developing Countries: The Case of Mexico

This study, published in BMC Infectious Diseases, developed a model to compare the cost and disease burden of rotavirus in unvaccinated children in Mexico. The study determined that it would be highly cost-effective to include rotavirus vaccine in the national immunization program, especially among poorer populations and those with less access to medical care.

Author: Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R

Published: 2008

» Visit web page (English)

(Located at www.pubmedcentral.nih.gov)

Citation: Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R. Cost-effectiveness of Introducing a Rotavirus Vaccine in Developing Countries: The Case of Mexico. BMC Infectious Diseases. 2008;8:103-116.

Resource types: Peer-reviewed journal

Diseases/vaccines: Rotavirus

Topics: Immunization financing, Disease burden and surveillance, Disease/vaccine specific information

Regions: Latin America and the Caribbean